Specimen Collection from Pregnant Women At Increased Risk for Fetal Aneuploidy (NCT01429389)
Collection of Whole Blood Specimens from Pregnant Women At Increased Risk of Fetal Chromosomal Abnormality for Use in Development of a Noninvasive Prenatal Test in the Detection of the Relative Quantity of Chromosomal Material in Circulating Cell-Free DNA Extracted from Maternal Plasma
🩺 Plain-English Summary (8th-Grade Level)
The specimen collection is designed for the purpose of the development of a noninvasive prenatal test for T21.
Who can join: Review the eligibility criteria below.
Location: University of Alabama Birmingham — Birmingham, Alabama
Age range: 18 Years
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (14 Sites)
- University of Alabama Birmingham — Birmingham, Alabama
- Cedars-Sinai Medical Center — Los Angeles, California
- Sharp-Rees Stealy Medical Group — San Diego, California
- UCSD — San Diego, California
- Women's Health Care Research — San Diego, California
- Specialty Obstetrics of San Diego — San Diego, California
- Reproductive Genetics Institute — Chicago, Illinois
- University of Iowa Health Care — Iowa City, Iowa
- Henry Ford Hospital — Detroit, Michigan
- Spectrum Health — Grand Rapids, Michigan
- The Cooper Health System — Camden, New Jersey
- Medical University of South Carolina — Charleston, South Carolina
- IWK Health Centre — Halifax, Nova Scotia
- North York General Hospital — Toronto, Ontario
📞 Contact the Study Coordinator
Phone: (205) 934-5509
Email: rachel.copper@obgyn.uab.edu
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Down Syndrome
- Evaluating Treatment of ADHD in Children With Down Syndrome — Sacramento, California
- Effects of Hypoglossal Nerve Stimulation on Cognition and Language in Down Syndrome and Obstructive Sleep Apnea — Atlanta, Georgia
- Using Personal Mobile Technology to Identify Obstructive Sleep Apnea in Children With Down Syndrome (UPLOAD) — Ottawa, Ontario
- Executive Function Play Opportunities for Children With Down Syndrome — Fort Collins, Colorado
- Escalating Doses of Memantine in Down Syndrome (MEDS-123) — Cleveland, Ohio
- Natural History of Dysregulation and Aging of the Immune System in People With Trisomy 21 With and Without Thymectomy — Bethesda, Maryland
Explore by condition: All Down Syndrome clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.